Eisai Co, Biogen Inc.’s Alzheimer’s drug gets EU’s marketing approval
HQ Team April 16, 2025: Eisai Co., Ltd. and Biogen Inc.’s drug to treat Alzheimer’s disease got marketing authorisation in the European Union,
HQ Team April 16, 2025: Eisai Co., Ltd. and Biogen Inc.’s drug to treat Alzheimer’s disease got marketing authorisation in the European Union,
HQ Team April 16, 2025: The 194 Member States of the WHO have reached a consensus on a draft agreement to strengthen global
HQ Team April 15, 2025: Using artificial intelligence Stanford researchers have developed a “digital twin” of a part of a mouse brain that
HQ Team April 15, 2025: Harvard University has rejected demands from US President Donald Trump’s administration that threaten $9 billion in research funding.
HQ Team April 15, 2025: Bristol Myers Squibb’s end-phase trial to test a drug for treating a heart condition, where the muscle of
HQ Team April 13, 2025: Cambridge researchers have invented a device to record heart sounds accurately and diagnose coronary valve diseases better than
HQ Team April 13, 2025: Johnson & Johnson MedTech’s arm, Shockwave Medical Inc. has started human trials to assess the effectiveness of its
HQ Team April 13, 2025: A new pandemic like Covid-19 is “not a theoretical risk, it is an epidemiological certainty,” said the World
HQ Team April 12, 2025: A European Space Agency satellite is slated for launch on April 29 to gather information about the state